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Monokines and platelet-derived growth factor modulate prostanoid
production in growth arrested, human mesangial cells. Previous studies
have demonstrated considerable prostanoid production by cultured
proliferating rat mesangial cells (MC). In this study, human mesangial
cells (HMC) were examined during serum-free culture in which the cells
were reversibly growth arrested and did not suffer obvious irreversible
functional changes. Non-stimulated cells released 2 to 10 pg/24 hr/pg
cellular protein of PGE2, PGF2,, 6-keto-PGF1, while TXB2 was not
detectable. Stimulation with interleukin-113 (IL-l/3) or tumor necrosis
factor a (TNFa) induced up to 18-fold (IL-l$) or up to fourfold (TNFa)
increases of prostanoid release. Combinations of the two monokines
resulted in significant synergistic induction of PGE2 and 6-keto-PGF1
up to 38 times that of control cells. Interleukin-6 (IL-6) and the
HMC-mitogen, platelet-derived growth factor-BB (PDGF-BB) only
induced marginal increases in HMC prostanoid generation. However,
when PDGF-BB or -AB was combined with IL-l/3 or IL-6, prostanoid
generation by HMC was synergistically increased up to 222-fold (IL-l/3)
or 12-fold (IL-6) above the control values, with the induction of PGE2
> 6-keto-PGF1, > PGF2,. >> TXB2. In the case of IL-lf3 + PDGF-BB
the induction of PGE2 release was at least partly due to the synergistic
induction of cyclooxygenase activity. These findings demonstrate that
both proliferating and reversibly growth arrested HMCs release pros-
taglandins in response to various inflammatory stimulators and combi-
nations thereof. The findings support the important role of HMC in the
regulation of glomerular hemodynamics during inflammatory processes.
The culture of mesangial cells (MC) has become an important
tool to elucidate potential mechanisms which may be involved
in the pathogenesis of giomerular disease [1]. Thus it has been
shown that rat MC in culture may release and/or respond to a
wide range of mediators, including prostaglandins [2, 31, inter-
leukin-l (IL-i) [3, 4], tumor necrosis factor a (TNFa) [5],
platelet-derived growth factor (PDGF) [6], oxygen radicals [71
and platelet activating factor [8]. Although there are only few
reports using human mesangial cells (HMC), these have con-
firmed some of the findings [9—11]. In many of the studies
cultured MCs proliferating in the presence of fetal calf serum
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have been examined. However, the physiological in vivo state
of the MC is a growth arrested cell and (ill-characterized)
substances in the fetal calf serum may influence their metabolic
functions or may interfere with their response to stimuli.
Several authors therefore have attempted to examine the cells
under "resting" conditions. For this the cells have usually been
transferred from culture in medium containing 10% fetal calf
serum to that containing 0.5% fetal calf serum or 0.5% bovine
serum albumin for 24 hours prior to the commencement of the
experiment. This experimental design, however, may still be
influenced by the presence of ill-characterized substances in the
fetal calf serum, and the cells may not be in a truly resting state
but rather in a transitional phase. Furthermore, it is not known
whether this procedure induces irreversible functional changes
in MCs. In view of these shortcomings we have attempted to
establish a model in which HMCs can be maintained in a
growth-arrested, viable state, under conditions of serum-free
culture for prolonged periods of time, without causing irrevers-
ible alterations to the cells.
We have recently demonstrated that in common with rat MC
[2, 3] proliferating HMCs in culture are capable of releasing
high amounts of prostaglandins [12, 13], confirming the earlier
work of Ardaillou et a! [9]. The prostaglandins secreted by
HMCs in culture show a distinct profile [13] clearly different
from that released from macrophages, supporting the concept
that intrinsic MCs rather than bone marrow-derived cells,
which represent a small percentage of glomerular cells [14],
were examined. A marked enhancement of prostanoid produc-
tion has been shown in rat cells to occur after stimulation with
IL-i [3]. In addition, it has been suggested that cytokine
receptor expression may differ in proliferating and non-prolif-
erating cells [3] and that the cellular responses to mediators
(such as IL-i) may vary between these two cell stages. Because
of this, it was of interest to evaluate whether qualitative or
quantitative changes of basal and stimulated prostaglandin
release are observed when cultured HMCs are examined in a
growth arrested rather than in a proliferative state. In this
report we present evidence that HMCs under growth arrested
conditions show a quantitatively lower, but not qualitatively
altered, production of prostanoids in response to non-specific
859
860 Floege et a!: Prostanoid production by human mesangial cells
cell activators such as calcium ionophore A 23187 or various
inflammatory stimuli. The main eicosanoids released from
growth arrested HMCs were PGE,, PGF2,, and PGI2 (as mea-
sured by 6-keto-PGF1a), while only small amounts of throm-
boxane A2 (TxA2, as measured by TxB2) synthesis could be
demonstrated. Prostanoid production was greatly enhanced by
the monokines IL-1$ and TNFa, while interleukin-6 (IL-6)
showed little stimulatory activity. The AA- and BB-homodi-
mers of PDGF as well as the AB-heterodimer also showed only
a small induction of prostanoid secretion. Significantly syner-
gistic prostanoid induction was observed for the combination of
IL-1f3 and TNFa as well as for the combination of PDGF (-BB,
-AB) and either IL-l/3 or IL-6. These findings stress the
potential importance of inflammatory mediators in the induction
and regulation of glomerular prostanoid secretion.
Methods
Agonists
Human recombinant IL-1f3 (Biogen/Glaxo, Geneva, Switzer-
land) was from Dr. J. M. Dayer, Geneva (specific activity was
2 x 108 U/mg as assessed in a mouse thymocyte assay; 1 U was
equivalent to 50 pg of IL-lf3 as assessed in a specific radloim-
munoassay [15]. Recombinant human TNFa was supplied by
BASF (Ludwigshafen, FRG). Its specific activity was l0 U/mg
as assessed in a cytolysis bioassay, and 1 U corresponded to
100 pg in a TNFa radioimmunoassay [161. The AA-homodimer,
BB-homodimer and AB-heterodimer of human recombinant
PDGF was expressed of fusion protein with /3-galactosidase in
E. co/ias described [17, 18]. Human recombinant IL-6 was also
expressed in E. coli as described [19]. Calcium ionophore
A23 187 (diluted in dimethyl suiphoxide and stored at —70°C
until required) and lipopolysaccharide from S. Minnesota Re
595 were obtained from Sigma Chemical Company (St. Louis,
Missouri, USA), while arachidonic acid was obtained from
Nucheck Prep. Inc. (Elysion, New Jersey, USA).
Establishment of human mesangial cell cultures
After the patients (age range 45 to 75) had given their
informed consent, normal human kidney tissue (confirmed
histologically) was obtained at the time of elective nephrectomy
for encapsulated renal carcinomas. Following sharp dissection
the tissue was immediately placed in ice-cold phosphate-
buffered saline (PBS), pH 7.4. The renal medulla was then cut
off and the remaining tissue was homogenized. The glomeruli
were recovered by passage through serially graded sieves, as
has been described elsewhere in detail [lii. Contamination of
non-glomerular tissue in the achieved preparation was <1% as
determined by phase contrast microscopy. The glomeruli were
then incubated in PBS, containing bacterial collegenase (Type
CLS 4, 184 U/mg, Worthington Biochemical Corporation, Free-
hold, New Jersey, USA) at a final concentration of 1 mg/mI in
a shaking water bath at 37°C for 30 to 40 minutes. The resultant
glomerular remnants were washed twice with growth medium
containing 10% heat-inactivated fetal calf serum (Gibco, Egg-
enstein, FRG). Growth medium consisted of RPM! 1640, sup-
plemented with 100 U/mI penicillin, 100 /Lg/ml streptomycin, 2
mM/mi L-glutamine, 2 mM/mi sodium-pyruvate and 0.01 mllml
non-essential amino acids (all obtained from Gibco). Further-
more, 5 gJml bovine insulin and 5 g/ml human transferrin
(both from Sigma) were added to the growth medium. The
glomerular remnants after the washing steps were plated in
growth medium containing 20% fetal calf serum at 37°C in a
humidified 5% CO2 atmosphere. Cellular outgrowths appeared
within three to five days and consisted of mostly strap-like cells
growing in interwoven bundles. All other cell types were
scraped off and the remaining cells were then replated and
grown to confluency. The concentration of fetal calf serum was
reduced to 10% between the second and third passage. All
experiments were performed using cells between the fourth and
tenth passage derived from at least three different kidneys. All
cells were free of mycoplasma as assessed by repeat staining
with 4' ,6-diamidine-2'-phenylindole dihydrochioride (DAPI;
Boehringer, Mannheim, FRG).
Morphological and immunohistochemical ce/I
characterization
Confluent cells grew in interwoven layers and had a uniform
appearance with no microscopic evidence of the presence of
either glomerular endothelial or epithelial cells. For the immu-
nohistochemical characterization the cells were seeded onto
glass microscope slides at low density. After attachment the
cells were fixed with acetone/methanol (50:50 vol/vol; 4°C).
Subsequent immunofluorescent staining of the cells, as de-
scribed elsewhere in detail [11], revealed prominent intracellu-
lar staining for myosin, MHC I antigen as well as significant
amounts of vimentin and extracelluiar type IV collagen and
fibronectin. Immunofluorescence staining was negative for cy-
tokeratin, factor VIII associated antigen and MHC II surface
antigens.
Cell culture in serum-free medium
For the transfer of the cells to serum-free medium they were
seeded in 24- or 6-well culture dishes (Costar, Cambridge,
Massachusetts, USA) or 250 ml tissue culture flasks (Nunc,
Wiesbaden, FRG) and allowed to reach subconfluency in
growth medium containing 10% fetal calf serum. The cells were
then washed once with PBS and thereafter serum-free medium
was added to the cells. For the serum-free culture MCDB 302
medium (Sigma) was used, which was supplemented with 100
U/mI penicillin, 100 sgIml streptomycin, 2 mM/mi L-glutamine,
5 sg/ml bovine insulin and 5 jsg/ml human transferrin.
Determination of cell growth
Cell growth was determined in 24-well culture dishes (Costar)
in three ways. The first was by direct counting of the cells per
well after trypsinization.
Alternatively each well was pulsed with 100 j.d 25 nmolar
3H-thymidine (specific activity 6.3 Ci/mmol; NEN products,
Dreieich, FRG). After a two hour incubation at 37°C the cell
supernatant was taken off and the cells where washed twice
with PBS containing an excess of non-labelled thymidine (Sig-
ma). Five hundred microliters of 5% (wt/vol) TCA were then
added and the cells were incubated at 4°C for one hour. After
this time the TCA was aspirated and 0.25 ml 0.1 N NaOH were
added. This was followed by incubation for another hour at
37°C, after which 0.5 ml 0.1 N NaOH/0.1 N HCI (1:3, vol/vol)
were added. Five tenths milliliter of the solution obtained were
then used for liquid scintillation counting, while the remaining
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0.25 ml were stored for determination of total protein using a
modification of the Bradford assay [201.
In a third experimental design, cell growth was determined
microscopically by the two hour incorporation of 5-bromo-
2'-deoxyuridine/5-fluoro-2 '
-deoxyuridine and subsequent local-
ization of labelled DNA using a monoclonal anti-5-bromo-
2'-deoxyuridine antibody and a peroxidase based immunological
detection system (Cell proliferation kit; Amersham-Buchler,
Braunschweig, FRG).
Prostaglandin induction
HMCs were grown to greater than 80% confluency in 24 well
plates (Costar) and switched to serum-free culture as described.
After 48 hours the cells were washed once with serum-free
medium and incubated at 37°C with or without the agonist to be
tested. At defined time intervals the HMC culture medium was
removed, centrifuged at 12000 g for 10 minutes and the super-
natant was removed and stored at —70°C until the assay. The
cellular layer remaining was washed with PBS, pH 7.4 and the
cellular protein solubilized for one hour at 37°C in 0.1 N NaOH.
Total cellular protein was determined using a modified Bradford
assay [201. Repeated cell counts revealed that 1 jig of cellular
protein was equivalent to 2.5 x l0 cells (N = 15). Control
experiments showed that 48 hour incubation of growth arrested
HMCs with various concentrations of IL-1f3, TNFa (and com-
binations thereof) and IL-6 neither led to a significant increase
of cell counts or total cellular protein. In contrast, PDGF led to
a concomittant increase of cell counts and cellular protein,
which showed a significant correlation (10 ng!ml PDGF-BB: y =
0.95x + 0.007, N = 15, r = 0.85,P < 0.001; 10 ng/ml PDGF-AB:
y = 0.90x + 0.11, N = 9, r = 0.82, P < 0.001; 10 ng!ml
PDGF-AA: y = l.l6x + 0.09, N = 8, r = 0.71, P < 0.05).
Prostaglandin radioimmunoassays
Radioimmunoassays were used to quantitate the concentra-
tions of PGE2, TxB2, 6-keto-PGF1 and PGF2,, present in the
supernatants of cultured HMCs. The polyclonal antisera (raised
in this laboratory) and techniques used in these assays have
been described elsewhere in detail [211. Briefly, samples were
incubated overnight with the appropriate 3H-eicosanoid tracer
(5,000 cpm!tube, NEN Products), specific rabbit antiserum, and
goat anti-rabbit gamma-globulin antiserum (Calbiochem, Frank-
furt, FRG) at 4°C. The double antibody-eicosanoid complexes
were then separated by centrifugation, dissolved in 0.1 N NaOH
and the radioactivity determined by liquid scintillation count-
ing. Eicosanoid levels were calculated by comparison with
calibration standards ranging from 10,000 to 2.4 pg/tube (detec-
tion limit in all assays). Prostaglandin production was expressed
as pg/jig cellular protein.
None of the antisera employed showed crossreactivity with
l0— M arachidonic acid. The relative cross reactivities with
related prostanoids were determined by the 50% displacement
technique as follows:
a) anti-PGE2: 1.2% for PGD2, 1.1% for TxB7, < 0.4% for
6-keto-PGF1,, and PGF2,.
b) anti-6-keto PGF1,: <0.1% for PGD2 and TxB2, 0.3% for
PGF2,, 0.4% for PGE2.
c) anti-PGF7,,: <0.1% for PGD2, TxB2, 6-keto-PGF1 ,,PGE.
d) anti-TxB2: <0.1% for PGD2, 6-keto-PGF1a, PGE2; <0.2%
for PGF2,.
High-performance liquid chromatography (HPLC)
HMC were grown to confluence in 250 ml tissue culture flasks
(Nunc), switched to serum-free culture for 48 hours, and
thereafter washed twice with PBS and prelabeled for 24 hours at
37°C with 5 jiCi/flask (5, 6, 8, 9, 11, 12, 14, 15, 3H(N))-
arachidonic acid (NET-2982, 191 Ci!mmol, NEN Products) in
PBS containing calcium (1 mM), magnesium (1 mM) and 1%
wt/vol D-glucose, pH 7.4 (PBS-medium). Subsequently the
cells were washed three times with fresh PBS-medium contain-
ing 0.1% wt/vol fatty acid free bovine serum albumin (Sigma),
and then twice with PBS-medium alone. The cells were then
stimulated with ionophore A 23187 (1 jiM in PBS-medium) for
30 minutes at 37°C. Prostanoids were purified from the super-
natants by solid phase extraction on 1 ml C18-octadecylsilyl
columns (ODS, Analytichem International, Harbour City, Cal-
ifornia, USA) and separated by reverse phase HPLC (Bruker-
Franzen Analytik, Bremen, FRG) on a MZ micro Nucleosil
120-SC18 column (250 x 1.6 mm, MZ Analysetechnik, Mainz,
FRG). The mobile phase consisted of 37.9% water, 62% aceto-
nitrile, 0.1% acetic acid (96% voLlvol) adjusted to an apparent
pH of 4.5 with sodium acetate with a flow rate of 0.1 mllmin.
Fractions of the column were collected and their radioactivity
measured (Minaxi tri-carb /3-counter 4000 series, Canberra!
Packard GmbH, Frankfurt a.M., FRG). The peaks of radioac-
tivity measured were compared to those of authentic tritiated
standards (NEN Products) run on the same day (legend of Fig.
6).
cyclo-oxygenase activity
Cyclo-oxygenase activity was assessed by the modification of
a previously described method [21].
HMC were grown in 250-ml tissue culture flasks (Nunc,
FRG), washed three times with culture medium, and stimulated
for various times at 37°C with the agonist(s) to be tested. The
cells were then washed three times with ice-cold PBS and
harvested by gentle scraping of the flask surface with a rubber
policeman (Tecnomara, Fernwald, FRG). These cells were then
sonicated for 3 x 5 seconds at 50 W (Braun, Labsonic 1510,
Melsungen AG. Mainz, FRG) at 4°C, centrifuged at 600 x g to
remove the nucleus and cell debris and the supernatant was
centrifuged at 100,000 x g for 30 minutes at 4°C (Beckman
L8-70 Ultracentrifuge, Beckman Instruments GmbH, Han-
nover, FRG) and the pellet collected and kept at 4°C. The
amount of crude membrane protein was assessed in a modified
Bradford assay [20].
Protein from the crude membrane preparation was resus-
pended in 50 mivi HEPES/140 mrvi KCI buffer (pH 8.0). The
assay mixture contained in a total volume of 200 jil: 8 jiM
bovine hemoglobin (type H2625, Sigma), 320 mivt DL-tryp-
tophan (Sigma, FRG), 3.75 mrvi gluthathione (Boehringer Mann-
heim GmbH, FRG) and 20 jig of membrane protein. The
mixture was preincubated for 10 minutes at 37°C. Diclofenac
(250 jiM, Sigma, FRG) was added as a specific cyclooxygenase
inhibitor in control tubes. The assay was started by the addition
of iO arachidonic acid (Sigma, FRG) and proceeded for 30
minutes at 37°C. At this time point, the reaction was stopped by
freezing the assay mixture in liquid nitrogen. The mixture was
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Fig. 1. Phase contrast microscopical appearance of proliferating (A) and growth arrested (B) HMCs (after 48 hours of serum-free culture) (X300).
subsequently centrifuged at 12,000 x g and the PGE2 content of
the supernatant measured by radioimmunoassay, as described.
The data was calculated and expressed as pg PGE,/mg protein!
mm.
Statistics
Statistical significance (defined as P < 0.05) was evaluated by
means of the Wilcoxon signed rank test for non-parametric
populations. All values are given as mean SD.
Results
Table 1. Twenty-four-hour PGE2 release of proliferating HMCs (cells
in medium containing 10% fetal calf serum) in response to IL-1f,
TNFa and lipopolysaccharide S. Minnesota Re 595 (LPS) before
(N = 8) and after an eight-day growth-arrest period (N = 4)
PGE2 pg/irg cellular protein
Before growth After growth
Stimulus arrest arrest
Medium 9±4 12±6
LL-1/35 nglml 1079 246 605 440
TNFa 10 ng/ml 153 93 206 62
LPS 100 ng/ml 550 158 235 114
Cell culture in serum-free medium
Preliminary experiments showed, that the addition of insulin
and transferrin to the serum-free medium was necessary in
order to keep the cells viable.
As shown in Figure 1, phase contrast microscopy demon-
strated that morphological changes of the HMCs occurred after
48 hours of serum-free culture. The cells tended to flatten and to
assume a more polygonal shape in contrast to the spindle-type
shape of proliferate cells. Possibly as a consequence of cellular
spreading, intracellular fibrils became more prominent. Granu-
lar material attached to the cells, most likely representing
extracellular matrix (positive immunohistochemical staining
with anti-fibronectin), increased with time of serum-free cul-
ture. No further changes of the cells occurred if they were
cultured under serum-free conditions for periods longer than 48
hours.
To determine whether culture in serum-free medium causes
irreversible changes in HMCs, growth medium was replaced by
serum-free medium for eight days, after which the cells were
switched back to growth medium again. Following one passage
in growth medium the ability of the cells to release prostaglan-
dins in response to various stimuli was compared to results
obtained with cells not exposed to serum-free culture condi-
tions. As shown in Table 1, the cells under both conditions were
able to release PGE2 in response to IL-1/3, TNFn or lipopoly-
saccharide Re 595. Cell duplication time (determined during the
logarithmic phase of growth) was similar at 32.6 5.2 hours (no
growth arrest; N = 3) and 29.5 4.8 hrs (after an 8 day period
of growth arrest; N = 3). Furthermore, neither phase contrast
microscopic characteristics nor the ability of the cells to grow
for at least five further passages without microscopically de-
tectable alterations were altered after the eight-day serum-free
culture period.
Incubation of subconfluent cells with 3H-thymidine at daily
intervals following the switch from growth medium to serum-
free medium showed an initial steep decrease, which leveled off
after 48 hours (Fig. 2A). At each time point, up to four days,
5H-thymidine incorporation could be stimulated by the addition
of 10% fetal calf serum (Fig. 2A). As control cells in growth
medium also showed a decrease of the 3H-thymidine incorpo-
ration (Fig. 2A), which paralleled the increasing confluence of
the cells, direct cell counting experiments were performed,
which confirmed the cessation of proliferation in HMCs cul-
tured in serum-free medium but not of the cells maintained in
growth medium (Fig. 2B). Additionally these experiments
showed a slow decrease of cell numbers under serum-free
conditions with time (Fig. 2B). Similar results were obtained
when determinations of total protein were performed (results
not shown). If not stated otherwise, all subsequent experiments
were therefore performed with cells that were cultured in
serum-free medium for 48 hours prior to the commencement of
the experiment.
Cell growth was assessed microscopically by the two hour
incorporation of 5-bromo-2 '
-deoxyuridine/5-fluoro-2'-deoxyuri-
dine. As shown in Figure 3A, subconfluent cells in growth
medium showed staining of 22.5 12.3% (N = 15) of the nuclei
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Fig. 2. A. Two-hour 3H-thymidine incorporation rates of subconfluent (at 0 hours) HMCs cultured in growth medium () or following the switch
to serum-free medium (U). Cells cultured in serum-free medium (a), with 10% fetal calf serum (FCS) added 24 hours before the 3H-thymidine
pulse. Data are mean SD, N = 6. NS = not significant; *p < 0.05. B. Relative cell count per well for subconfiuent (at 0 hours) HMCs cultured
either in growth medium (•) or following the switch to serum-free medium (U). Data are means SD, N = 6. *P < 0.05 versus 100%.
Fig. 3. Two-hour nuclear incorporation of 5-bromo-2'-deoxyuridine/
5-fluoro-2'-deoxyuridine in HMCs in growth medium (A) and in cells
under serum-free conditions (144 hours after the switch from growth
medium) (B); x 300. Controls included cells not exposed to 5-
bromo-2'-deoxyuridine/5-fluoro-2 '-deoxyurine (C).
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Fig. 4. Two-hour 3H-thymidine incorporation(expressed as % of the incorporation rate at
24 hours) rates of subconfluent (N = 4, El) or
confluent (N = 4, U) growth arrested HMCs
(after 48 hours in serum-free medium) under
32 36 40 48 non-stimulated conditions, Data are means
SD.
(depending on the degree of confluency), while the staining in
subconfluent cells cultured under serum-free conditions de-
creased to 4.1 2.5%(N= 9) after 48 hours and 3.3 2.2%(N
= 10) after 144 hours (Fig. 3B). Controls containing no 5-
bromo-2'-deoxyuridine/5-fluoro-2'-deoxyuridine (Fig. 3C) or no
anti-bromo-deoxyuridine antibody did not show any nuclear
staining.
Endogenous ce/I growth in serum-free medium
Cells were cultured in serum-free medium for 48 hours, the
medium changed and 3H-thymidine was added to the medium at
the indicated subsequent intervals (Fig. 4). While 3H-thymidine
incorporation remained constant for the next 24 hours, a small
peak was observed 36 hours after the change of medium in four
of the eight experiments. Further analysis of the data showed
that the occurrence of this peak was related to the degree of
confluency of the cells at the start of the experiment (Fig. 4).
Determination of total protein per well at 48 hours confirmed
the difference between the two groups of experiments: in the
subconfluent group total protein amounted to 11.9 3.5 g/
well, while that in the confluent group was 25.4 3.0 pg/well.
In subconfluent cells the occurrence of this incorporation peak
was not influenced by the presence of either diclofenac 106 M
or indomethacin 10—6 M in the medium, despite complete
suppression of prostanoid production at this concentration
(data not shown). The effects of the protein-synthesis inhibitor
cycloheximide or of the DNA-synthesis inhibitor actinomycin
D on the peak could not be evaluated, as even concentrations of
10 nglml of either substance resulted in increased cell death
under the conditions of serum-free culture.
Prostaglandin re/ease during serum-free culture
Figure 5 depicts 1 hour and 24 hour basal and stimulated
release of PGE2, TxB2, 6-keto-PGF,, and PGF2, into the
medium at 48 or 96 hours after the switch to serum-free culture.
Low concentrations of PGE2, 6-keto-PGF1a, PGF2a and TxB2
were measurable in 24 hour supernatants of non-stimulated
cells (with PGE, > 6-keto-PGF1a> PGF20 >> TxB2). Follow-
ing stimulation with fetal calf serum, IL-l13, arachidonic acid or
ionophore A 23187, the generation of all four prostanoids was
increased, with mostly the same hierarchical response pattern.
Comparison of the magnitude of the responses to the stimuli at
48 or 96 hours after the switch to serum-free culture revealed
that PGE2, PGF2, and TxB2 release in response to IL-1/3 was
significantly higher at 96 hours than at 48 hours (P < 0.05).
Interestingly, significantly higher release rates at 96 hours were
also observed for 6-keto-PGF1, in response to ionophore and
arachidonic acid as well as for PGF2 in response to ionophore,
while the release rate of PGE2 in response to arachidonic acid
decreased at 96 hours.
Control experiments excluded that the increased prostanoid
production of HMC in response to recombinant IL-1j3 (or the
other recombinant stimulators) was due to endotoxin contami-
nation, as even high concentrations of lipopolysaccharide (LPS)
did not induce PGE2 release under the conditions of serum free
culture (medium: 7.6 5.3 pg PGE2/24 hr/pg protein; 1000
ng/ml LPS: 9.8 4.3 pg/24 hr/jtg protein; N = 4).
As shown in Figure 6, HPLC of supernatants of growth
arrested HMCs after a 30 minutes stimulation with 2 sg/ml
ionophore A 23187 confirmed that the predominant prostanoid
species in the cells were PGE2, 6-keto-PGF1 and PGD2, while
lesser amounts of PGF2,, and TxB2 were detected.
Twenty-four hour stimulation with IL-1f3, TNFa, IL-6,
PDGF AA, -AB or -BB induced variable responses (Table 2).
Little or no release of PGE2, TxB2, 6-keto-PGF1a and PGF2a
were observed with PDGF (AA, AB or BB), while at the same
time 10 ng/ml of PDGF-AB or PDGF-BB, and to a lesser degree
PDGF-AA, induced significant proliferation of HMCs: the 24
0 8 12 16 24
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hour increase of the 3H-thymidine incorporation rate (ex-
pressed as % of the medium control, which was set at 100%)
amounted to 302 146% (AB; N = 9;P < 0.01 vs. control), 277
160% (BB; N = 15;P < 0.01 vs. control) and 153 30% (AA;
N = 6; P < 0.05 vs. control). These results were confirmed by
direct cell counting experiments (data not shown). No signifi-
cant 24 hour release of prostanoids was observed with IL-6. In
contrast, a dose-dependent stimulation of PGE2, 6-keto-PGF1,
and PGF2, production occurred in response to both IL-l/3 or
TNFa, with significant release of TxB2 release only detectable
at high concentrations of IL-lf3. Neither IL-l$, IL-6 nor TNFr
significantly increased growth under the conditions of this study
(unpublished results; manuscript in preparation). The combina-
tion of IL-1f3 and TNFa was shown to have significant syner-
gistic effects (P < 0.05 vs. additive effect) on PGE2 and
6-keto-PGF1,,, while the effect on PGF2, or TxB2 production
was not significantly different from the additive effect of both
monokines alone. Significant synergistic effects (P < 0.05 vs.
additive effect) were also observed for the combination of
PDGF (BB, AB) with IL-1/3 and in some cases with IL-6 (Table
2).
As shown in Figure 7, the release of PGE2 in response to
stimuli occurred in a time-dependent fashion. Significant pro-
duction of PGE2 was evident by 48 hours of stimulation of the
cells with 10 ng/ml PDGF-BB or 100 U/mI IL-6 (measurements
of PGE2 in the supernatant after short-term incubation, that is,
1 or 2 hours did not disclose an early, transient PGE2 produc-
tion; data not shown). IL-l/3 (5 nglml) induced a marked release
of PGE2 after a 12 hour lag-phase. Both, the response towards
IL-6 as well as that towards IL- 113 could be augmented signif-
icantly if these monokines were added in combination with
PDGF-BB (10 ng/ml).
All observed effects of monokines or PDGF on HMC pros-
tanoid release were independent of cell passage number, cell
confluency or donor.
Cyclo-oxygenase activity
Table 3A shows that in growth-arrested HMC cyclo-oxyge-
nase activity was inducible in the cell membrane fraction by
prior incubation of the cells for  12 hours with 5 nglml IL- 113.
An increase of cyclo-oxygenase activity was also noted after
36 hour incubation with 10 nglml PDGF-BB as opposed to
IL-6, where no such increase occurred at any time point
examined. Combinations of IL-1/3 and PDGF-BB led to a more
than additive induction of cyclo-oxygenase activity after  six
hour preincubation. In contrast, when PDGF was combined
with IL-6, cyclo-oxygenase activity did not exceed that ob-
served with PDGF alone.
To test the ability of growth arrested HMC to metabolize
exogenous arachidonic acid to PGE2, HMC were incubated for
I or 12 hours with IL-1J3, IL-6, PDGF-BB and combinations
thereof. After this time the medium was replaced by fresh rest
medium and 2 g/ml arachidonic acid was added. After further
incubation for one hour, PGE2 concentration in the supernatant
was measured. As shown in Table 3B and confirming the results
shown in Figure 5, arachidonic acid had a markedly stimulatory
effect on cellular PGE2 release in non-stimulated cells. Prestim-
ulation of the cells for one hour with IL-l/3, IL-6, PDGF-BB
and combinations did not lead to a further increase of PGE2
release, while after preincubation for 12 hours PGE2 was higher
C
E
0
0
2
FCS
Fig. 5. HMC release of PGE2 (U), TxB2 (, 6-keto-PGF1 () and
PGF, (0) into the culture mediwn at 48 or 96 hours after the switch
from growth medium to serumiree culture. Cells were either incubated
for 1 hour with medium alone, 2.5 sgfml arachidonic acid or I sg/ml
ionophore A 23187 or they were incubated for 24 hours with medium
alone, 5 nglml interleukin-1/3 or 10% fetal calf serum (FCS). Data are
mean SD; N = 6; P < 0.05 versus corresponding 48 hour value.
in IL- 113 stimulated cells and was markedly increased in IL-j3 +
PDGF-BB stimulated cells. No such increase was noted in IL-6
or PDGF-BB + IL-6 stimulated cells.
Discussion
The transfer of data derived from cell cultures to the in vivo
situation is a controversial issue. However, in order to investi-
gate the potential in vivo reaction patterns of cells, a purist
experimental situation, in which variables have been reduced as
far as possible is desirable. In this study a model of cultured
HMCs is therefore described, which allows the prolonged
culture of the cells in the absence of fetal calf serum or other
protein additives without inducing obvious, irreversible cellular
changes. This is indicated by the absence of morphologic
alterations in proliferating cells as well as by their similar
growth kinetics and response to stimuli before and after an
eight-day period of serum-free culture. These findings also
support the assumption that despite the fact that a significant
number of cells are lost during serum-free culture (possibly
A
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C
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0
C
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CU00
Med. 1 hr lonoph. Ara. Acid Med. 24 hr IL-1
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representing normal cell turnover) no HMC subpopulation with
altered behavior is selected by this procedure. In accordance
with others [10], it was found that the addition of insulin and
transferrin to the medium were required to maintain viable cells
Fig. 6. HPLC elution profile of 3H
cyclooxygenase products released into the
culture medium of growth arrested HMCs
after 24 hour incubation of the cells with 3H-
arachidonic acid and subsequent 30 minute
stimulation with 2 i.g/ml ionophore A 23187
(Methods). Arrows indicate peaks which
correspond to those obtained with authentic
tritiated prostaglandins, which had the
following retention times (N = 3,
respectively): 6-keto PGFIa — 10.3 2.1 mm,
30 TxB2 — 13.3 1.0 mm, PGF2a — 15.1 0.8
mm, PGE2 — 19.2 0.9 mm and PGD2 —
22.3 0.5 mm.
over prolonged periods of serum-free culture. In contrast to the
absence of detectable functional or morphological cellular al-
terations pre- and post-serum-free culture, alterations of the
cells were noted during this period. Cellular morphology was
Table 2. Twenty-four hour release of GE2, 6-keto-PGF,, PGF2a and TxB2 (all expressed in pg4g ccl
in response to various stimuli
lular protein) by growth arrested HMCs
Stimulus concentration in ng/mla N PGE2 6-keto-PGF,,, PGFa TXB2
None 8 7±5 4±3 2±2 ND
IL-1/3 (0.05)
IL-1/3 (0.5)
JL-113(5)
6
6
6
10 2 4 2
62 51" 4"
128 92" 33 22"
2 26 2
23 15"
ND
0.5 03b
1.4 0,9b
TNFa (0.1) 6 7 1 4 3 3 I ND
TNFa (1)
TNFa (10)
6
6
17 12" 5 1
28 24b 8 3b
6 4
8 2'
ND
ND
IL-1/3 + TNFa(0,5 + 1)
IL-l/3 + TNF (0.5 + 10)
6
6
108 46b 21 6b
193 79" 57 29"
6 3
15 5b
0.6 0.5"
0.7 0.5"
IL-113 + TNFs (5 + 10) 6 265 80" 142 70b 61 38b 1.3 1.0"
IL-6 (1C') 5 3 3 3 1 3 I ND
IL-6 (10) 5 2 1 1 1 4 3 ND
IL-6 (100k) 5 8 7 4 4 5 4 ND
PDGFAA(1) 4 11±5 3±1 5±2 ND
PDGF AA (10) 4 8 4 4 2 3 2 ND
PDGFAB(1) 4 8±6 3±1 4±3 ND
PDGFAB(I0) 4 11±9 6±2 4±1 ND
PDGF BB (1) 4 10 6 3 1 4 2 ND
PDGFBB(10)
PDGFAA 10 + IL-113(10 + 5)
4
6
11±5 6±3
86 75" 91 f()b
6±3
104 43"
ND
1.3 0.8"
PDGF AA 10 + IL-6 (10 + l00) 5 7 4 2 I 4 3 ND
PDGF AB 10 + IL-1$ (10 + 5)
PDGFAB 10 + IL-6(10 + 100)
PDGF BB 10 + IL-l/3 (10 + 5)
PDGFBB 10+ IL-6(l0+ 1oo)
6
5
6
5
573 313" 465 240"
14 3b 49 32b
726 544" 254 138''
41±26"' 24± 12b
444 3b
27 15"
341 105"
9 3b
2.6 1.1"
ND
3.3
ND
ND, not detectable.
a IL-6 concentrations are expressed in U/mI
b P < 0.05 versus corresponding values with no stimulus
6-Keto
PGE2
PGD2
6.0
5.0
4.0
3.0
5 10 15 20 25
'a
Ui
0
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changed in such that the cells tended to become more polygonal
and the intracellular fibrils became more prominent. In addition
to these morphological findings, it was obvious that a rapid
reduction in cell growth occurred in serum-free medium, which
was however not complete, as studies on the cellular level
demonstrated that 3.3% of the cells were still cycling even six
days after the switch to serum-free medium. It seems, therefore
that, at least in HMCs, even complete serum-deprivation is not
adequate to induce a non-cyclicing, synchronized cell popula-
tion. It is tempting to relate the described model of HMC
culture to the in vivo situation, where it has been shown that in
contrast to glomerular epithelial cells a low percentage of MCs
are constantly cycling [22]. Detailed analysis of the growth
kinetics of HMCs revealed that in subconfluent, but not in
confluent cell layers a small, isolated peak of 3H-thymidine
incorporation occurred at 3.5 days (84 hrs) after the switch to
serum-free culture. These data further confirm that HMC
growth does not cease completely in serum-free medium. The
reasons for this peak remain unclear, but might involve auto-
crine secretion of growth factors by the cells, such as IL-i and
PDGF-like activity [4, 6], or stimulation of cellular growth as a
result of altered matrix production. The results of this study
only excluded that this growth phenomenon was related to
prostanoid secretion.
Comparison of the non-stimulated and stimulated release
pattern of prostaglandins in the growth arrested HMCs with
that of the same cells in a proliferating state (as described
elsewhere [13]) showed that a qualitatively similar, but quanti-
tatively lower hierarchical response pattern of PGE2 > 6-
keto-PGF1> PGF2 >> TxB2 occurred under the conditions
of this study. Independent of whether the stimulus was recep-
tor-mediated as in the case of IL-l13, TNFa and possibly IL-6,
or whether it was induced by the Ca2-ionophore A 23187 or
the prostaglandin precursor arachidonic acid, this hierarchical
Table 3. A. Cyclo-oxygenase activity associated with the crude
membrane fraction of growth arrested HMC after various times of
preincubation with LL-1/3, IL-6, PDGF-BB or combinations thereof
Cyclo-oxygenase activity pg PGE2
after prestimulaton for:
1mg/mm
36 hr
(Separate
Stimulus 1 hr 6 hr 12 hr exp.)
Medium ND/ND ND/ND 366/490 1782
PDGF 351/1032 ND/1l16 309/496 4740
IL1/3b 1014/895 ND/1045 1724/1426 8140
PDGF ÷ IL-113 1814/829 ND/7190 2980/3647 95620
Medium ND ND 35 1782
PDGF 71 65 80 4740
IL-6' 163 89 98 1760
PDGF ÷ IL-6 201 60 117 3860
Data are values of sing
Table 3. B. PGE2
Ic experiments determined in quadruplicate.
release into the supernatant of HMC
PGE2 pg/jsg cellular protein
Stimulus
after preincubation of HMC for:
1 hr 12 hr
Medium 244 77 222 53
IL-113t' 191 98 298 97
1L6c 218 69 186 85
PDGF 262 90 236 63
PDGF + LL-1/3 190 61 606 147
PDGF+IL-6 191±64 253±82
Cells were incubated for 1 or 12 hours with medium alone, IL-l/3,
IL-6, PDGF-BB or combinations thereof. Following this the medium
was removed and the cells were incubated for a further hour with 2.0
g/ml arachidonic acid after which PGE2 in the supernatant was
determined. Data are mean SD, N = 3.
a io ng/ml PDGF-BB
b 5 ng/ml
100 Jm1
ND, not determined.
PDGF B8 IL-i
IL-i
LPDGF BB + IL-6
IL-6
PDGF BB
Medium
0 12 24 36 48
Time, hours
Fig. 7. Time dependency of the release of
PGE2 by growth arrested HMCs in response
to 5 ng/ml IL-IfJ, 100 U/mi IL-6, 10 ng/ml
PDGF-BB and combinations thereof Data are
mean SD, N = 6, *D < 0.05 versus medium
control.
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response was always present, indicating activation of all the
enzymes of the cyclo-oxygenase pathway in the stimulated
cells. The data obtained are qualitatively comparable to those
observed in proliferating rat MCs, except that in these cells a
hierarchical release pattern of PGE2 > PGF2, > 6-keto-PGF1
>> TxB2 has been reported [21. However, in contrast to earlier
reports on growth arrested rat MCs [31 the responsiveness of
growth arrested HMCs towards IL-l/3 was preserved under the
conditions prevailing in this study, as IL-1f3 was shown to be
not only a potent inducer of all prostaglandin species examined
but also increased the cyclo-oxygenase activity associated with
the cell membrane. This finding implies the presence of a
functioning IL-i receptor on the growth arrested HMCs. Initial
attempts to demonstrate the presence of an IL-i receptor on
these cells however have failed, which may be related to
receptor occupation due to an endogenous IL-i production [41
and/or the presence of low receptor numbers on these cells.
Interestingly, the responsiveness of the cells towards IL-lf3
increased significantly for several prostaglandin species with
the time of serum-free culture. This finding indicates that either
the absolute number or the number of non-occupied IL-i
receptors may even increase with time of serum-free culture, a
fact which might be related to the demonstrated cessation of
endogenous IL-i production in HMCs under growth arrested
conditions [10].
In addition to IL-i/3, TNFa in the concentrations examined
also proved to be a potent stimulator of PGE2, PGF2, and
6-keto-PGF1a synthesis, which again is qualitatively similar to
that observed in rat MCs [23]. In analogy to results obtained
with proliferating HMCs with PGE2 secretion [12], a signifi-
cantly synergistic effect of IL- 1/3 and TNFa on PGE2 and
6-keto-PGF1 production was shown for growth arrested
HMCs, This effect is possibly related to an induction of late
enzymes in the synthetic pathway of these prostagiandins [121.
IL-6, the third cytokine tested, only exhibited weak effects on
HMC prostaglandin production. Analysis of the time kinetics of
IL-6 induced PGE2 production showed a long lag-phase (24
hrs), indicating that the action of IL-6 may be mediated via
induction of other HMC products, such as IL-i [24].
In the case of both recombinant human IL-l/3 and IL-6, the
induction of prostaglandin synthesis in the growth arrested
HMCs was not accompanied by a proliferative response during
the time of the study (unpublished observations, manuscript in
preparation). On the other hand, the HMC mitogen PDGF-BB,
while inducing significant proliferation of growth arrested cells,
showed only a minor late, though significant effect on PGE2
production. This effect was probably attributable to the induc-
tion of cyclo-oxygenase activity by PDGF-BB. In this respect
HMC seem to differ from fibroblasts, where PDGF has been
shown to be a potent and much more rapid inducer of cyclo-
oxygenase activity and PGE2 release [251. When BB-homodi-
mers or AB-heterodimers of PDGF, that is, the two PDGF
types naturally occurring in platelets [261, were combined with
the monokines IL-1J3 or IL-6, a marked synergistic induction of
prostaglandin release was observed. The same concentrations
of the AA-homodimer of PDGF yielded a lesser effect in such
experiments, which was paralleled by a lesser mitogenic poten-
tial of this PDGF type for the HMCs. The explanation for this
in the case of IL-1/3 may reside in the finding that combinations
of IL-i and PDGF increased cell membrane-associated cyclo-
oxygenase activity in a synergistic manner. This was supported
by indirect experiments in which HMCs prestimulated with
IL-i and PDGF were capable of synthesizing increased
amounts of PGE2 from exogenously-added arachidonic acid.
However, further mechanisms may also be involved in the
synergy between IL-i and PDGF as PDGF has been shown to
induce IL-i receptor expression in fibroblasts and/or to modu-
late the cellular responsiveness towards IL-i 1271. In contrast to
PDGF + IL-1j3, the PGE2 production induced by the combina-
tion of PDGF and IL-6 only became apparent after a 24 hour
lage-phase. Since no synergistic induction of cyclo-oxygenase
could be demonstrated in this case, this finding may indicate
that other mechanisms may operate by which increased pros-
taglandin production is facilitated [12], such as the induction of
phospholipase A2 or receptor modulating effects.
Thus, the results of this study show, that HMCs may release
significant amounts of prostaglandins in response to various
monokines, independent of whether they are in a growth
arrested state or whether they have been induced to proliferate.
Due to the problems inherent to the application of cell culture
derived data to the in vivo situation one can only speculate on
the possible (patho-)physiological relevance of these results.
There are, however, recent in vivo findings which indicate that
monokines and PDGF may be involved in the pathological
sequalae of various types of human or experimental glomerular
inflammation [28—31]. No matter whether the monokines and
PDGF (-like proteins) are released in a paracnne fashion from
infiltrating monocytes or platelets in the glomerulus or in an
autocrine fashion from the MCs themselves [32], these recent
findings support the assumption that the stimulatory mecha-
nisms for prostaglandin production observed in vitro may also
be operative in vivo. It is intriguing to speculate that this
stimulation of HMC prostaglandin production, with PGE2 and
prostacyclin as the main species, in an inflammatory response
may at least in part account for the observation of a prostaglan-
din dependent, increased glomerular blood flow and vasodila-
tation [33], no matter whether the glomerular disease is associ-
ated with MC proliferation or not. Furthermore, increased
glomerular concentrations of PGE2 may be involved in the
antagonism of angiotensin Il-induced mesangial cell contraction
and reduction of the filtering surface of the glomeruli [34—36].
These findings may help to explain the detrimental effects of
prostaglandin synthesis inhibitors on renal function under cer-
tain circumstances [reviewed in 37].
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